Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 6, 2022; 10(22): 7728-7737
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7728
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7728
Clinical performance evaluation of O-Ring Halcyon Linac: A real-world study
Guang-Yu Wang, Qi-Zhen Zhu, He-Ling Zhu, Zhi-Kai Liu, Fu-Quan Zhang, Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
Ling-Juan Jiang, Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China
Nan Zhao, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
Author contributions: Wang GY designed and performed the research and wrote the paper; Liu ZK and Zhang FQ designed the research and supervised the report; Zhu QZ and Zhu HL performed the research; Jiang LJ and Zhao N supervised the report.
Supported by the National Foundation for Education Sciences Planning , No. BLA 200216 ; and the National Key Research and Development Plan , Ministry of Science and Technology of the People’s Republic of China, No. 2016YFC0105207.
Institutional review board statement: The study was reviewed and approved by the Institutional Review Board of Peking Union Medical College Hospital (No. S-K1883).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrolment.
Conflict-of-interest statement: The authors have no conflict of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhi-Kai Liu, MD, Associate Professor, Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing, Dongcheng District, Beijing 100730, China. liuzk2009@126.com
Received: January 6, 2022
Peer-review started: January 6, 2022
First decision: February 8, 2022
Revised: March 7, 2022
Accepted: June 13, 2022
Article in press: June 13, 2022
Published online: August 6, 2022
Peer-review started: January 6, 2022
First decision: February 8, 2022
Revised: March 7, 2022
Accepted: June 13, 2022
Article in press: June 13, 2022
Published online: August 6, 2022
Core Tip
Core Tip: The fast-rotating coplanar O-ring Halcyon Linac has demonstrated many advantages in radiation therapy. Unlike previous studies, which focused more on the machine parameters and quality control aspects of the O-ring Halcyon Linac, our institution evaluated Halcyon more from the perspective of practical clinical applications concerning radiotherapy effects and irradiation toxicity. The O-ring Halcyon Linac can generate desired treatment plans that meet clinically accepted constraints, pass routine patient-specific quality assurance for delivery accuracy verification, and present acceptable radiation toxicity under prospective yield.